SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

4 Nov 2016 07:00

RNS Number : 3068O
Tullett Prebon PLC
04 November 2016
 

4 November 2016

Tullett Prebon plc

 

 

 

Q3 Trading Update

 

Tullett Prebon plc is today issuing a trading update in relation to the period from 1 July to 30 September 2016.

 

Revenue in the third quarter to 30 September 2016 of £216m was 15% higher than the £188m revenue for the same period last year, and 4% higher at constant exchange rates. In the nine months to September, revenue of £647m was 7% higher than the £603m revenue for the same period last year, and 2% higher at constant exchange rates.

Reported revenue grew strongly in the third quarter due to the impact of foreign exchange, with around 60% of the group's revenue denominated in US dollars. During the period we have benefited from volatility associated with political uncertainty and speculation around the potential for further interest rate increases.

 

In the first nine months we continued to benefit from our acquisitions in Energy and Commodities as the division increased revenue 10% year on year at constant exchange rates. Information Sales and RMS have continued to see strong growth in the current quarter, with an increase of 28% in revenue (at constant exchange rates). In the first nine months their revenue increased 20% (at constant exchange rates).

 

In November 2015, we announced the proposed acquisition of the global hybrid voice broking and information businesses of ICAP plc. We are continuing to work with ICAP towards securing the outstanding regulatory approvals for completion of the transaction, including from the FCA.

 

John Phizackerley, Tullett Prebon CEO, said: "This has been a satisfactory quarter, with a number of products and regions showing gains. While some trading conditions remain challenging, our strategy of diversification and cost control is proving effective."

 

 

Notes to Editors

 

Tullett Prebon (www.tullettprebon.com) is one of the world's leading interdealer brokers and operates as an intermediary in wholesale financial markets facilitating the trading activities of its clients in seven major product groups: Energy & Commodities, Rates, Volatility, Treasury, Non-Banking, Credit and Equities.

With offices in 24 countries, Tullett Prebon operates voice, hybrid, electronic, volume matching, algorithmic matching and risk mitigation platforms, to accommodate the needs of its clients, and to satisfy the regulatory driven evolution of the marketplace. In addition to its brokerage services, Tullett Prebon offers a variety of market information services through its IDB Market Data division, Tullett Prebon Information.

Tullett Prebon has its principal offices in London, New Jersey, Hong Kong, Singapore and Tokyo, with other offices, joint ventures and affiliates in Bangkok, Connecticut Dubai, Frankfurt, Geneva, Houston, Jakarta, Johannesburg, Luxembourg, Madrid, Manama, Manila, Mexico City, Mumbai, New York, Paris, São Paulo, Seoul, Shanghai, Sydney, Toronto, Vienna and Warsaw.

Enquiries:

Tullett Prebon plc

 

Analysts/investors:

Sam Dobbyn, +44 (0)20 7200 7147

sdobbyn@tullettprebon.com

 

Media:

Rebecca Shelley, +44 (0)20 7200 7750

rshelley@tulletprebon.com

 

Brunswick Group

 

Kim Fletcher

Eilis Murphy

+44 (0)20 7404 5959

tullettprebon@brunswickgroup.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKXLFBQFFBFBE
Date   Source Headline
5th Jan 20172:13 pmRNSHolding(s) in Company
4th Jan 201711:38 amRNSHolding(s) in Company
3rd Jan 20175:51 pmRNSTotal Voting Rights
30th Dec 20168:05 amRNSAdmission of new shares
30th Dec 20167:00 amRNSCompletion of transaction with NEX
28th Dec 201611:07 amRNSChange of Name
28th Dec 20167:00 amRNSStatement re transaction with NEX
9th Dec 20167:00 amRNSDividend Declaration
6th Dec 20161:40 pmRNSStatement re transaction with ICAP
1st Dec 201610:02 amRNSHolding(s) in Company
23rd Nov 201611:29 amRNSHolding(s) in Company
15th Nov 201612:09 pmRNSStatement re transaction with ICAP
4th Nov 20167:00 amRNSTrading Statement
1st Nov 201612:52 pmRNSDirector Declaration
3rd Oct 20162:34 pmRNSTP ICAP Global Executive Committee
3rd Oct 20162:29 pmRNSTullett Prebon Management Changes
3rd Oct 20169:55 amRNSTotal Voting Rights
27th Sep 20162:15 pmRNSAdditional Listing
26th Sep 20167:03 amRNSStatement re transaction with ICAP
12th Sep 20163:49 pmRNSPublication of Supplementary Prospectus
8th Sep 201612:20 pmRNSStatement on transaction with Tullett Prebon
8th Sep 201612:15 pmRNSStatement re transaction with ICAP
24th Aug 20162:15 pmRNSHolding(s) in Company
3rd Aug 20162:15 pmRNSDirector/PDMR Shareholding
2nd Aug 20169:08 amRNSNew Technology Centre, Belfast Northern Ireland
2nd Aug 20167:00 amRNSHalf-year Report
22nd Jul 20161:15 pmRNSStatement re transaction with ICAP
29th Jun 20166:00 pmRNSNotification of Interim Results
21st Jun 20166:25 pmRNSStatement re transaction with ICAP
20th Jun 201610:21 amRNSHolding(s) in Company
7th Jun 20167:09 amRNSStatement re. CMA announcement
6th Jun 20164:18 pmRNSHolding(s) in Company
16th May 201612:08 pmRNSPublication of Supplementary Prospectus
16th May 20167:13 amRNSIGBB FY 2016 results
13th May 201612:16 pmRNSDirectorate Change
13th May 201610:17 amRNSResult of AGM
12th May 20167:00 amRNSTrading Statement
6th May 20167:00 amRNSDirectorate Change
5th May 20164:41 pmRNSDirector/PDMR Shareholding
4th May 201612:51 pmRNSHolding(s) in Company
22nd Apr 20165:18 pmRNSDirector/PDMR Shareholding
19th Apr 20165:27 pmRNSDirector/PDMR Shareholding
5th Apr 20162:49 pmRNSPublication of Supplementary Prospectus
4th Apr 20164:48 pmRNSAnnual Financial Report
24th Mar 20162:16 pmRNSEGM Statement
1st Mar 201611:37 amRNSPublication of Prospectus
1st Mar 20167:00 amRNSStatement re acquisition
1st Mar 20167:00 amRNSFinal Results
5th Feb 20168:00 amRNSAdoption of Financial Reporting Standard (FRS)101
2nd Feb 20167:00 amRNSStatement re acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.